108 related articles for article (PubMed ID: 6112527)
1. Gonadal function in boys with steroid-responsive nephrotic syndrome treated with cyclophosphamide for short periods.
Trompeter RS; Evans PR; Barratt TM
Lancet; 1981 May; 1(8231):1177-9. PubMed ID: 6112527
[TBL] [Abstract][Full Text] [Related]
2. Gonadal function, testicular histology, and meiosis following cyclophosphamide therapy in patients with nephrotic syndrome.
Etteldorf JN; West CD; Pitcock JA; Williams DL
J Pediatr; 1976 Feb; 88(2):206-12. PubMed ID: 1249681
[TBL] [Abstract][Full Text] [Related]
3. Gonadal function in males treated with cyclophosphamide for nephrotic syndrome.
Hsu AC; Folami AO; Bain J; Rance CP
Fertil Steril; 1979 Feb; 31(2):173-7. PubMed ID: 761678
[TBL] [Abstract][Full Text] [Related]
4. Testicular function in prepubertal and pubertal male patients treated with cyclophosphamide for nephrotic syndrome.
Penso J; Lippe B; Ehrlich R; Smith FG
J Pediatr; 1974 Jun; 84(6):831-6. PubMed ID: 4826616
[No Abstract] [Full Text] [Related]
5. [Delayed effect of cyclophosphamide on testicular function after treatment of nephrotic syndrome in childhood].
Bogdanović R; Cvorić A; Banićević M; Zdravković D; Nikolić V; Ognjanović M
Srp Arh Celok Lek; 1990; 118(5-6):235-42. PubMed ID: 2127483
[TBL] [Abstract][Full Text] [Related]
6. Testicular function following cyclophosphamide treatment for childhood nephrotic syndrome: long-term follow-up study.
Bogdanović R; Banićević M; Cvorić A
Pediatr Nephrol; 1990 Sep; 4(5):451-4. PubMed ID: 2242303
[TBL] [Abstract][Full Text] [Related]
7. Postpubertal evaluation of gonadal function following cyclophosphamide therapy before and during puberty.
Lentz RD; Bergstein J; Steffes MW; Brown DR; Prem K; Michael AF; Vernier RL
J Pediatr; 1977 Sep; 91(3):385-94. PubMed ID: 894406
[TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie.
Arch Dis Child; 1987 Nov; 62(11):1102-6. PubMed ID: 3688915
[TBL] [Abstract][Full Text] [Related]
9. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
Behre HM; Nashan D; Hubert W; Nieschlag E
J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
[TBL] [Abstract][Full Text] [Related]
10. [Good results of cyclophosphamide in steroid toxicity in the treatment of nephrotic syndrome caused by minimal-lesion glomerulopathy in childhood].
de Moor R; de Jong M; Monnens L
Ned Tijdschr Geneeskd; 1992 May; 136(18):876-80. PubMed ID: 1589052
[TBL] [Abstract][Full Text] [Related]
11. Gonadal function in women treated with cyclophosphamide for childhood nephrotic syndrome: a long-term follow-up study.
Watson AR; Taylor J; Rance CP; Bain J
Fertil Steril; 1986 Aug; 46(2):331-3. PubMed ID: 3732541
[TBL] [Abstract][Full Text] [Related]
12. [Effect of cyclophosphamide on the reproductive function -- study of testicular histology in male patients with nephrotic syndrome (author's transl)].
Ogata H; Shibata T; Hirai Y; Aratani H; Yokoyama K; Shinzato K; Taura K; Harada T; Fujimatsu S; Horita S; Hara K; Shindo K; Matsuo T; Nakayama I
Nihon Jinzo Gakkai Shi; 1981 Feb; 23(2):213-21. PubMed ID: 7253320
[No Abstract] [Full Text] [Related]
13. Pituitary-gonadal function in women following cyclophosphamide treatment for childhood nephrotic syndrome: long-term follow-up study.
Bogdanović R; Banićević M; Cvorić A
Pediatr Nephrol; 1990 Sep; 4(5):455-8. PubMed ID: 2242304
[TBL] [Abstract][Full Text] [Related]
14. The effect of cyclophosphamide on children with steroid resistant nephrotic syndrome and its side effect upon the gonadal tissue.
Wila W; Alatas H; Tambunan T; Khow LP; Ramelan W
Paediatr Indones; 1976; 16(7-8):291-8. PubMed ID: 1004929
[No Abstract] [Full Text] [Related]
15. [Cyclophosphamide in idiopathic nephrotic syndrome: Outcome and outlook].
Berkane M; Adarmouch L; Amine M; Bourrahouat A; Ait Sab I; Sbihi M
Nephrol Ther; 2018 Apr; 14(2):85-90. PubMed ID: 29631702
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
Kyrieleis HA; Levtchenko EN; Wetzels JF
Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
[TBL] [Abstract][Full Text] [Related]
17. Chlorambucil in steroid-dependent nephrotic syndrome.
Penso JS; Olson DL; Robillard J; Smith FG
J Pediatr; 1973 Sep; 83(3):508-9. PubMed ID: 4725161
[No Abstract] [Full Text] [Related]
18. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L
Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide therapy in the nephrotic syndrome in childhood.
Moncrieff MW; White RH; Oggs CS; Cameron JS
Br Med J; 1969 Mar; 1(5645):666-71. PubMed ID: 5774315
[TBL] [Abstract][Full Text] [Related]
20. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY; Wu CY; Tsai IJ; Tsau YK
Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
